The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes | |
Article | |
关键词: NONALCOHOLIC FATTY LIVER; DE-NOVO LIPOGENESIS; C3 GENE VARIANTS; SKELETAL-MUSCLE; PYRUVATE-CARBOXYLASE; CELLULAR MECHANISMS; ENERGY-EXPENDITURE; METABOLIC SYNDROME; CGI-58 KNOCKDOWN; WEIGHT-REDUCTION; | |
DOI : 10.1038/nature13478 | |
来源: SCIE |
【 摘 要 】
Non-alcoholic fatty liver disease and its downstream sequelae, hepatic insulin resistance and type 2 diabetes, are rapidly growing epidemics, which lead to increased morbidity and mortality rates, and soaring health-care costs. Developing interventions requires a comprehensive understanding of the mechanisms by which excess hepatic lipid develops and causes hepatic insulin resistance and type 2 diabetes. Proposed mechanisms implicate various lipid species, inflammatory signalling and other cellular modifications. Studies in mice and humans have elucidated a key role for hepatic diacylglycerol activation of protein kinase C epsilon in triggering hepatic insulin resistance. Therapeutic approaches based on this mechanism could alleviate the related epidemics of non-alcoholic fatty liver disease and type 2 diabetes.
【 授权许可】
Free